Cytochrome P4502C9 activity in end-stage renal disease

Clin Pharmacol Ther. 2003 May;73(5):475-7. doi: 10.1016/s0009-9236(03)00015-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Alleles
  • Anticoagulants / blood
  • Aryl Hydrocarbon Hydroxylases / metabolism*
  • Cytochrome P-450 CYP2C9
  • Down-Regulation
  • Female
  • Genotype
  • Humans
  • Kidney Failure, Chronic / enzymology*
  • Male
  • Middle Aged
  • Warfarin / blood

Substances

  • Anticoagulants
  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases